Osteocalcin (1-49) (human) (trifluoroacetate salt)

Osteocalcin (1-49) (human) (trifluoroacetate salt)

CAT N°: 24723
Price:

From 693.00 589.05

Osteocalcin (1-49) is a non-collagenous peptide that is secreted by osteoblasts and odontoblasts and comprises 1-2% of the total protein in bone.{39529} Secretion of osteocalcin (1-49) is stimulated by 1,25-dihydroxy vitamin D and plasma levels increase in diseases that induce dysregulated bone turnover such as osteoporosis, Paget’s disease, and primary hyperparathyroidism.{39529,39530} Osteocalcin (1-49) is positively correlated with insulin sensitivity and negatively correlated with high blood glucose levels in women.{39531} In vitro, osteocalcin induces chemotaxis of MDA-MB-231 breast cancer cells, human peripheral blood monocytes, and rat osteosarcoma cells with osteoblast-like characteristics.{39530} It is also expressed by vascular smooth muscle cells (VSMCs) displaying an osteoblast-like phenotype and has been positively associated with calcification of aortic tissue and heart valves in humans.{39532}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • L-tyrosyl-L-leucyl-L-tyrosyl-L-glutaminyl-L-tryptophyl-L-leucylglycyl-L-alanyl-L-prolyl-L-valyl-L-prolyl-L-tyrosyl-L-prolyl-L-?-aspartyl-L-prolyl-L-leucyl-4-carboxy-L-?-glutamyl-L-prolyl-L-arginyl-L-arginyl-4-carboxy-L-?-glutamyl-L-valyl-L-cysteinyl-4-carboxy-L-?-glutamyl-L-leucyl-L-asparaginyl-L-prolyl-L-?-aspartyl-L-cysteinyl-L-?-aspartyl-L-?-glutamyl-L-leucyl-L-alanyl-L-?-aspartyl-L-histidyl-L-isoleucylglycyl-L-phenylalanyl-L-glutaminyl-L-?-glutamyl-L-alanyl-L-tyrosyl-L-arginyl-L-arginyl-L-phenylalanyl-L-tyrosylglycyl-L-prolyl-L-valine cyclic (23?29)-disulfide, trifluoroacetate salt
  • Correlated keywords
    • 136461-80-8 noncollagenous MB231 MDAMB231 BGP ?-Carboxyglutamic Acid Containing Protein
  • Product Overview:
    Osteocalcin (1-49) is a non-collagenous peptide that is secreted by osteoblasts and odontoblasts and comprises 1-2% of the total protein in bone.{39529} Secretion of osteocalcin (1-49) is stimulated by 1,25-dihydroxy vitamin D and plasma levels increase in diseases that induce dysregulated bone turnover such as osteoporosis, Paget’s disease, and primary hyperparathyroidism.{39529,39530} Osteocalcin (1-49) is positively correlated with insulin sensitivity and negatively correlated with high blood glucose levels in women.{39531} In vitro, osteocalcin induces chemotaxis of MDA-MB-231 breast cancer cells, human peripheral blood monocytes, and rat osteosarcoma cells with osteoblast-like characteristics.{39530} It is also expressed by vascular smooth muscle cells (VSMCs) displaying an osteoblast-like phenotype and has been positively associated with calcification of aortic tissue and heart valves in humans.{39532}

We also advise you